NEW YORK (GenomeWeb) — NanoView Biosciences said today that it has signed an agreement making Quantum Design International the exclusive distributor of its ExoView exosome characterization platform in Japan.
Under the terms of the agreement, Quantum's Tokyo-based subsidiary — called Quantum Design Japan — will distribute the system in Japan, becoming NanoView's first distributor in Asia. Additional terms were not disclosed.
The ExoView system — which was launched earlier this year — uses single particle interferometric reflective imaging sensing to detect the enhanced scattering of extracellular vesicles bound to a microarray surface via antibody/antigen interaction. The platform can measure the concentration and size of extracellular vesicles as small as 50 nanometers and requires no sample preparation, according to Boston-based NanoView.
In October, NanoView raised $10 million in a Series B financing round.